Master of Drug Development: Bio-Pharmaceutical Sciences (1st part) 1MGMO-BFW1 2010-2011  Title Semester Theory (hours) Practice/Exercises (hours) Credits Professor(s) Compulsory Courses Medicinal Chemistry 1st semester 75,00 10 Koen Augustyns Toxicology 1st semester 45,00 6 Hugo Neels Ingrid De Meester Pharmaceutics and Biopharmacy II 1st semester 45,00 90,00 12 Annick Ludwig Pharmaceutical legislation and deontology 1st semester 22,50 3 Luc F A Van Santvliet Pharmacotherapy and pharmaceutical care I 2nd semester 45,00 7 Guido De Meyer Theodoor Lescrinier Pharmaceutical technology 2nd semester 30,00 20,00 6 Annick Ludwig Wim Weyenberg Chemical structure determination of drugs 2nd semester 15,00 3 Magda Claeys Roger Dommisse Luc Pieters Clinical biology and set up and evaluation of clinical studies 2nd semester 15,00 3 Dirk Hendriks Omer E.H. Van Schoor Frank Martens Walter Cooreman Glenn Van den Bosch Pharmaceutical applications of molecular biology 2nd semester 30,00 4 Anne-Marie Lambeir Pharmaceutical analysis: supplements 2nd semester 22,50 40,00 6 Sandra Apers Magda Claeys Paul Cos Adrian Covaci Nina Hermans Master of Drug Development: Bio-Pharmaceutical Sciences (2nd part) 1MGMO-BFW 2010-2011  Title Semester Theory (hours) Practice/Exercises (hours) Credits Professor(s) Compulsory Courses Preclinical drug research 1st semester 30,00 6 Louis Maes Paul Cos Koen Augustyns Clinical drug research 2nd semester 30,00 6 Pierre Van Damme Master thesis drug development 2nd semester 560,00 30 Roger Kemel module 'Policy, management and entrepreneurship', compulsory courses: Organisation management 1st semester 30,00 6 Paul Matthyssens Financial management and legal aspects 2nd semester 30,00 6 Tony Van Kerckhoven Eddy Laveren module 'Policy, management and entrepreneurship, minimum 1 course to choose from: Strategic Business Communication 1st semester 30,00 6 Luuk Van Waes Mariëlle Leijten Innovation and entrepreneurship 1st semester 30,00 6 Johan Braet